Catalent wins vaccine grant; TD2 partners up for cancer trials;

> CRO TD2 has partnered with Navigating Cancer, a patient-engagement outfit, to collaborate on clinical trials. Item

> Catalent ($CTLT) received a grant to help develop vaccines that don't need cold-chain storage. More